Jeff Yass’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-2,538
Closed -$467K – 8824
2018
Q4
$467K Buy
+2,538
New +$409K ﹤0.01% 6158
2018
Q1
– Sell
-2,063
Closed -$364K – 9312
2017
Q4
$364K Buy
+2,063
New +$366K ﹤0.01% 7233
2016
Q1
– Sell
-8,200
Closed -$1.88M – 8996
2015
Q4
$1.88M Sell
8,200
-3,013
-27% -$775K ﹤0.01% 4150
2015
Q3
$3.46M Sell
11,213
-26,000
-70% -$6.13M ﹤0.01% 3255
2015
Q2
$8.96M Buy
37,213
+34,663
+1,359% +$8.6M ﹤0.01% 2137
2015
Q1
$704K Buy
2,550
+1,387
+119% +$424K ﹤0.01% 6460
2014
Q4
$428K Buy
1,163
+150
+15% +$62.5K ﹤0.01% 7519
2014
Q3
$488K Sell
1,013
-1,002
-50% -$533K ﹤0.01% 7262
2014
Q2
$1.15M Sell
2,015
-1,563
-44% -$1.08M ﹤0.01% 5757
2014
Q1
$2.55M Buy
+3,578
New +$2.39M ﹤0.01% 3917

Other funds holding BIS

Jeff Yass's BIS Position: Q3 2026 in Review

Jeff Yass increased its ProShares UltraShort NASDAQ Biotechnology (BIS) stake by 25% in Q3 2026, buying an estimated $138K and bringing the position to 55,615 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #9151.

Jeff Yass first reported a position in BIS in Q2 2013 and has held it in 37 quarters since. The position peaked at $3.63M in Q3 2015. 3 funds tracked by Wall St. Rank hold BIS as of Q3 2026.

  • Jeff Yass held 55,615 shares of ProShares UltraShort NASDAQ Biotechnology worth $621K as of Q3 2026.
  • Jeff Yass bought 11,256 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2026, an estimated $138K.
  • ProShares UltraShort NASDAQ Biotechnology made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9151 holding.
  • Jeff Yass first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2013 and has held it in 37 quarters since.
  • Jeff Yass's ProShares UltraShort NASDAQ Biotechnology position peaked at $3.63M in Q3 2015.
  • 3 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.